https://www.selleckchem.com/products/ms-275.html
Both scans were negative for bone lesions in 7 patients (25%). Of 699 lesions consistent with skeletal metastasis in 21 patients on fluoride PET/CT, PSMA PET/CT identified 579 lesions (83%). In 69 identical bone lesions fluoride PET/CT showed significantly higher uptake (mean SUV 73.1 ± 36.8) compared to PSMA PET/CT (34.5 ± 31.4; p 0.001). Compared to CE-CT, PSMA PET/CT showed better diagnostic performance in locating local (96% vs 61%, p = 0.004) and lymph node (94% vs 46%, p 0.001) metastasis. In this prospective comparative
Gefällt mir
Kommentar
Teilen
